| Recruiting | 2/3 | 5 | Europe | Tecfidera (BG12), Gilenya, fingolimod, Tysabri®, natalizumab, Avonex/Betaseron/Copaxone/Rebif, (Avonex®, Betaseron®, Copaxone®, Rebif®), Hematopoietic stem cell transplantation (HSCT) | Sheffield Teaching Hospitals NHS Foundation Trust | Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting | 12/21 | 12/21 | | |